BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uozumi T, Seki H, Matsuzono E, Sogabe S, Sugai N, Fujita J, Suzuki J, Akimoto M, Yanai M, Suzuki A. Gastric adenocarcinoma of fundic gland type arising from heterotopic gastric glands during a 19-year follow-up period. Clin J Gastroenterol 2019;12:556-61. [PMID: 31165461 DOI: 10.1007/s12328-019-00989-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wada K, Tazawa H, Komo T, Hadano N, Onoe T, Sudo T, Shimizu Y, Kuraoka K, Suzuki T, Tashiro H. Gastric adenocarcinoma appearance in leiomyoma: A case report. Int J Surg Case Rep 2020;71:327-30. [PMID: 32492645 DOI: 10.1016/j.ijscr.2020.05.050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Liu L, Han L, Ma Q, Zhang J. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e25861. [PMID: 34032698 DOI: 10.1097/MD.0000000000025861] [Reference Citation Analysis]
3 Meng X, Yang G, Dong C, Zheng R. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021;13:203636132110601. [DOI: 10.1177/20363613211060171] [Reference Citation Analysis]
4 Wang D, Wang J, Song J, Shen Q, Wang R, Lu W, Pan J, Xie C, Liu M. Guanidyl and imidazolyl integration group-modified PAMAM for gastric adenocarcinoma gene therapy. J Gene Med 2020;22:e3240. [PMID: 32558063 DOI: 10.1002/jgm.3240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]